Vemurafenib (PLX-4032)-induced keratoses: Verrucous but not verrucae

Journal of the American Academy of Dermatology

Volumn 69, Issue 2, 2013, Pages

  Ko, Christine J ^a   McNiff, Jennifer M ^a   Iftner, Angelika ^b   Iftner, Thomas ^b   Choi, Jennifer Nam ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VEMURAFENIB;

ACTINIC KERATOSIS; ADULT; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; LETTER; METASTATIC MELANOMA; PAPULE; PRIORITY JOURNAL; SEBORRHEIC KERATOSIS; SQUAMOUS CELL CARCINOMA; VERRUCA VULGARIS;

EID: 84880364556     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.03.027     Document Type: Article

References (5)

1. O. Forslund, A. Antonsson, P. Nordin, B. Stenquist, and B.G. Hansson A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumors and normal skin J Gen Virol 80 1999 2437 2443
2. N.T. Harvey, M. Millward, and B.A. Wood Squamoproliferative lesions arising in the setting of BRAF inhibition Am J Dermatopathol 34 2012 822 826
3. P.A. Oberholzer, D. Kee, P. Dziunycz, A. Sucker, N. Kamsukom, and R. Jones RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors J Clin Oncol 30 2012 316 321
4. D. Weedon Viral diseases D. Weedon, Dermatopathology 2010 Elsevier China 608 631
5. B.J. Braakhuis, R.H. Brakenhof, C.J. Meijer, P.J. Snijders, and C.R. Leemans Human papilloma virus in head and neck cancer: the need for a standardized assay to assess the full clinical importance Eur J Cancer 45 2009 2935 2939